查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1436222

滥用药物 (DOA) 测试 2024 年全球市场报告

Drugs of Abuse (DOA) Testing Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

滥用药物 (DOA) 测试市场规模预计在未来几年将显着成长。预计到 2028 年将以 9.6% 的复合年增长率 (CAGR) 增长至 104.8 亿美元。未来预测期内的预计增长与运动和竞技测试的扩大、药物测试意识和教育的提高、毒品相关犯罪的迅速增加、企业健康计划的实施以及测试方法的进步有关。可能性。预计这段时期的主要趋势包括可携式和手持式检测设备的使用、实验室资讯管理系统（LIMS）的引入、合成药物检测的重点、大麻检测需求的增加以及结果解释的人工智慧。（AI）整合等

药物滥用治疗需求的成长预计将推动药物滥用 (DOA) 检测市场的成长。物质滥用或药物滥用涉及个人对物质的有害使用。药物测试在识别体内通常不存在的化合物方面发挥着重要作用。测试过程包括筛检测试，以检测和确认特定物质的存在。由于对药物滥用治疗的需求不断增加，预计该市场将会扩大。例如，2021年6月，联合国毒品犯罪防制署（UNODC）在其《世界毒品报告》中报告称，全球有超过3,600万人患有吸毒障碍。对药物滥用治疗的需求不断增长是滥用药物 (DOA) 检测市场成长的关键驱动力。

医院需求的不断增长预计将推动滥用药物（DOA）检测市场的扩大。作为一个综合医疗保健机构，医院在为患病或受伤的个人提供广泛的医疗服务、治疗和护理方面发挥着重要作用。在医院内整合滥用药物 (DOA) 检测有助于及早发现药物滥用，实现客製化治疗计划，增强临床决策，确保患者安全并提高公共安全。为卫生、职场安全和医疗资源的有效利用做出贡献。截至 2023 年 8 月，英国共有 1,148 家医院，凸显了医院在医疗保健服务中所扮演的重要角色。因此，医院需求的增加是推动滥用药物（DOA）检测市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球滥用药物 (DOA) 测试市场，按产品和服务细分、绩效和预测，2018-2023、2023-2028、2033
  • 分析仪
  • 快速检测装置
  • 消耗品
  • 检验服务
  • 全球滥用药物 (DOA) 测试市场，按样本类型细分、实际和预测，2018-2023、2023-2028、2033
  • 尿
  • 头髮
  • 口腔液
  • 呼吸
  • 全球滥用药物 (DOA) 测试市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 疼痛管理
  • 刑事司法
  • 职场筛检
  • 全球滥用药物 (DOA) 测试市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断实验室
  • 法医学研究所
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球滥用药物 (DOA) 测试市场、地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球滥用药物 (DOA) 测试市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 滥用药物（DOA）检测市场的竞争格局
  • 滥用药物 (DOA) 测试市场公司概况
    • Siemens AG
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 其他大型创新公司

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Zimmer Biomet Holdings Inc.
  • bioMerieux Inc.
  • Dragerwerk AG &Co. KGaA
  • Natera Inc.
  • Aegis Sciences Corporation
  • NMS Labs
  • Clinical Reference Laboratory Inc.
  • Cordant Health Solutions
  • Millennium Health
  • ACM Global Laboratories
  • Psychemedics Corporation
  • Alfa Scientific Designs Inc.
  • Alere Toxicology Services

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r15548

Drug of abuse (DOA) testing involves examining substances, such as drugs, chemicals, or plant products, typically used recreationally. This includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are screened for on a drug panel. Clinical screening methods use the patient's urine, saliva, blood, hair, or sweat for this purpose.

Drug of Abuse (DOA) testing encompasses various products and services, including analyzers, rapid testing devices, consumables, and laboratory services. Analyzers, automatic devices measuring chemical concentrations, play a crucial role in this domain. The testing involves sample types such as urine, hair, oral fluid, and breath, with applications in pain management, criminal justice, and workplace screening. End-users of DOA testing include hospitals, diagnostic laboratories, forensic laboratories, and other relevant entities.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth witnessed in the historical period can be ascribed to factors such as government regulations and workplace policies, pre-employment screening practices, law enforcement and legal procedures, drug rehabilitation programs, and compliance measures within the transportation industry.

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The projected growth in the upcoming forecast period can be linked to the expansion of sports and athletics testing, heightened awareness and education regarding drug testing, a surge in drug-related crimes, the adoption of corporate wellness programs, and advancements in testing methods. Key trends anticipated in this period encompass the utilization of portable and handheld testing devices, the implementation of Laboratory Information Management Systems (LIMS), a focus on synthetic drug testing, a growing demand for cannabis testing, and the integration of artificial intelligence (AI) for result interpretation.

The rising demand for drug abuse treatment is anticipated to drive the growth of the drugs of abuse (DOA) testing market. Drug abuse, or substance abuse, involves the harmful use of substances by individuals. Drug testing plays a crucial role in identifying compounds not typically present in the body. The testing process includes screening tests followed by confirmatory tests to detect and verify the presence of specific substances. The growing need for drug abuse treatment is expected to contribute to the market's expansion. For example, in June 2021, the United Nations Office on Drugs and Crime (UNODC) reported in the World Drug Report that over 36 million individuals worldwide have drug use disorders. This increasing demand for drug abuse treatment is a key driver for the growth of the drugs of abuse (DOA) testing market.

The growing demand for hospitals is anticipated to drive the expansion of the drugs of abuse (DOA) testing market. Hospitals, as comprehensive healthcare institutions, play a crucial role in delivering a broad spectrum of medical services, treatment, and care for individuals facing illness or injury. The integration of drugs of abuse (DOA) testing within hospitals facilitates early detection of substance abuse, enabling customized treatment plans, enhancing clinical decision-making, ensuring patient safety, and contributing to public health, workplace safety, and efficient healthcare resource utilization. As of August 2023, there are reported to be 1148 hospitals in the UK, emphasizing the significant role hospitals play in healthcare services. Hence, the increasing demand for hospitals is a key factor propelling the growth of the drugs of abuse (DOA) testing market.

Major players in the drugs of abuse (DOA) testing market are directing their efforts towards developing cutting-edge products, including software-as-a-service (SaaS) platforms, to reinforce their market presence. Software-as-a-Service (SaaS) represents a software distribution model where applications are hosted by a third-party provider and accessed by customers over the internet. A notable example is the introduction of the Addison drug discovery software by Merck KGaA, a US-based science and technology company, in December 2023. This software accelerates drug development and enhances the success rate of novel medications and therapies by integrating computer-aided drug design, machine learning, and generative AI. Addison provides recommendations on optimal methods for synthesizing medications, bridging the gap between virtual molecule design and practical manufacturability. By extracting hidden insights from extensive datasets, the platform increases the likelihood of patients benefiting from innovative treatments.

Key players in the drugs of abuse (DOA) testing market are actively introducing new products, including advanced drug testing, to stay ahead in the market competition. Drug testing involves analyzing biological specimens, such as urine, to identify specific drugs or their metabolites. In December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services, launched urine drugs of abuse testing services. These services are known for their ease of use, rapid effects, and affordability. The laboratory provides accredited urine drug testing services, ensuring high quality and precision in test results. Serving over 6,000 clients worldwide, the organization employs both screening and confirmatory testing in urine drug abuse testing services to ensure the accuracy and reliability of the results.

In February 2021, Thermo Fisher Scientific Inc., a US-based company specializing in scientific research services, entered into a partnership with Mindray Medical International Limited, a China-based medical technology company. The collaboration aims to provide clinical laboratories, hospitals, and the criminal justice system with reliable and cost-effective tools for drug misuse screening. This partnership allows Thermo Fisher Scientific to address the needs of testing facilities looking to enhance or expand their testing capabilities, as well as those seeking to integrate and centralize their testing processes.

Major companies operating in the drugs of abuse (doa) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMerieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

North America was the largest region in the drugs of abuse (DOA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs of Abuse (DOA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (doa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
  • 2) By Sample Type: Urine; Hair; Oral Fluid; Breath
  • 3) By Application: Pain Management; Criminal Justice; Workplace Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drugs of Abuse (DOA) Testing Market Size and Growth

  • 5.1. Global Drugs of Abuse (DOA) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drugs of Abuse (DOA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drugs of Abuse (DOA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drugs of Abuse (DOA) Testing Market Segmentation

  • 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Laboratory Services
  • 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Urine
  • Hair
  • Oral Fluid
  • Breath
  • 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Criminal Justice
  • Workplace Screening
  • 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Other End Users

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

  • 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

  • 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

  • 9.1. China Drugs of Abuse (DOA) Testing Market Overview
  • 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

  • 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

  • 11.1. Japan Drugs of Abuse (DOA) Testing Market Overview
  • 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

  • 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

  • 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

  • 14.1. South Korea Drugs of Abuse (DOA) Testing Market Overview
  • 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

  • 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
  • 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

  • 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

  • 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

  • 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drugs of Abuse (DOA) Testing Market

  • 19.1. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drugs of Abuse (DOA) Testing Market

  • 20.1. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drugs of Abuse (DOA) Testing Market

  • 21.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
  • 21.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drugs of Abuse (DOA) Testing Market

  • 22.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drugs of Abuse (DOA) Testing Market

  • 23.1. North America Drugs of Abuse (DOA) Testing Market Overview
  • 23.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drugs of Abuse (DOA) Testing Market

  • 24.1. USA Drugs of Abuse (DOA) Testing Market Overview
  • 24.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drugs of Abuse (DOA) Testing Market

  • 25.1. Canada Drugs of Abuse (DOA) Testing Market Overview
  • 25.2. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drugs of Abuse (DOA) Testing Market

  • 26.1. South America Drugs of Abuse (DOA) Testing Market Overview
  • 26.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drugs of Abuse (DOA) Testing Market

  • 27.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drugs of Abuse (DOA) Testing Market

  • 28.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
  • 28.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drugs of Abuse (DOA) Testing Market

  • 29.1. Africa Drugs of Abuse (DOA) Testing Market Overview
  • 29.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
  • 30.2. Drugs of Abuse (DOA) Testing Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drugs of Abuse (DOA) Testing Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings
  • 31.2. Quest Diagnostics Inc.
  • 31.3. Zimmer Biomet Holdings Inc.
  • 31.4. bioMerieux Inc.
  • 31.5. Dragerwerk AG & Co. KGaA
  • 31.6. Natera Inc.
  • 31.7. Aegis Sciences Corporation
  • 31.8. NMS Labs
  • 31.9. Clinical Reference Laboratory Inc.
  • 31.10. Cordant Health Solutions
  • 31.11. Millennium Health
  • 31.12. ACM Global Laboratories
  • 31.13. Psychemedics Corporation
  • 31.14. Alfa Scientific Designs Inc.
  • 31.15. Alere Toxicology Services

32. Global Drugs of Abuse (DOA) Testing Market Competitive Benchmarking

33. Global Drugs of Abuse (DOA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

35. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

  • 35.1 Drugs of Abuse (DOA) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drugs of Abuse (DOA) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drugs of Abuse (DOA) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer